Ugro Capital Limited has informed the Exchange regarding Outcome of Board meeting held on August 11, 2025.
UGROCAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ugro Capital's board approved its Q1 FY26 (quarter ended June 30, 2025) unaudited financial results, which were given an unmodified limited review by auditor Sharp & Tannan Associates. Total revenue from operations jumped to about ₹414 crore from ₹251.4 crore in the year-ago quarter, while profit after tax rose to ₹34.13 crore from ₹30.36 crore, and net worth strengthened to roughly ₹2,426 crore. Asset quality worsened slightly with Gross Stage 3 loans rising to 2.66% (from 2.35%) and Net Stage 3 to 1.49%, while capital adequacy improved to 22.36%. During the quarter, the company raised about ₹381 crore via a rights issue at ₹162 per share, completed a public NCD raise of up to ₹200 crore, and transferred loans worth about ₹364 crore via assignment and ₹263 crore via co-lending. The board also noted the resignation of nominee director Mr. Suresh Prabhala (from major shareholder ClearSky) and appointed Mr. Ramanathan Subramanian Arun Kumar as his replacement, subject to RBI approval. The proposed ₹1,398.6 crore acquisition of Profectus Capital and earlier ₹45 crore Datasigns Technologies deal remain pending regulatory clearances.
Strong revenue growth driven by interest income and loan-book expansion is positive, but the dip in net profit margin to 8.09% and a slight uptick in NPPA (asset quality) warrant close watch by shareholders. The large pending Profectus Capital acquisition, if approved, would be a transformative but leverage-heavy move for the company.